Cleared Traditional

2008T HD SYS. CDX BLUESTAR (191124); 2008T HD SYS. CDX W/bibag BLUESTAR (191126); 2008T HD SYS. W/O CDX BLUESTAR (191128); 2008T HD SYS. W/O CDX W/bibag BLUESTAR (191130)

K243237 · Fresenius Medical Care Renal Therapies Group, LLC · Gastroenterology & Urology
Jun 2025
Decision
246d
Days
Class 2
Risk

About This 510(k) Submission

K243237 is an FDA 510(k) clearance for the 2008T HD SYS. CDX BLUESTAR (191124); 2008T HD SYS. CDX W/bibag BLUESTAR (191126); 2008T HD SYS. W/O CDX BLUESTAR (191128); 2008T HD SYS. W/O CDX W/bibag BLUESTAR (191130), a Dialyzer, High Permeability With Or Without Sealed Dialysate System (Class II — Special Controls, product code KDI), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on June 13, 2025, 246 days after receiving the submission on October 10, 2024. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5860.

Submission Details

510(k) Number K243237 FDA.gov
FDA Decision Cleared SESE
Date Received October 10, 2024
Decision Date June 13, 2025
Days to Decision 246 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KDI — Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5860

Similar Devices — KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 341
multiFlux 130 (F00013123); multiFlux 160 (F00013124)
K252459 · Fresenius Medical Care Renal Therapies Group, LLC · Feb 2026
Tablo Hemodialysis System (PN-0008000, PN-0006000U)
K253412 · Outset Medical, Inc. · Jan 2026
FX CorAL 40; FX CorAL 50
K253518 · Fresenius Medical Care Renal Therapies Group, LLC · Dec 2025
Purema H Hemoconcentrator - Pediatric
K243920 · Medica USA, Inc. · Sep 2025
AK 98 Dialysis Machine (955607)
K250508 · Vantive US Healthcare, LLC · Aug 2025
5008X Hemodialysis System
K243505 · Fresenius Medical Care Renal Therapies Group, LLC · May 2025